K121902 is an FDA 510(k) clearance for the NATRATONE. Classified as Perineometer (product code HIR), Class II - Special Controls.
Submitted by Orelle Corporation, Ltd. (Seattle, US). The FDA issued a Cleared decision on June 6, 2013 after a review of 342 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 884.1425 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.
View all Orelle Corporation, Ltd. devices